FAMILY PRACTICE GUIDELINES JILL C
LEARNING WORKBOOK 2026 DIAGNOSTIC
APPROACHES AND TREATMENT PROTOCOLS
◉ Screening for Hearing Loss in Adults. Answer: USPSTF has
insufficient evidence to determine the benefits of screening for
hearing loss in asymptomatic adults over the age of 50
◉ Screening for Hepatitis B in Pregnant Women. Answer: Screen all
pregnant women
◉ Screening Test for Hepatitis B in Pregnant Women. Answer:
HBsAg detection, regardless of previous negative HBsAg results
◉ Timing of Screening for HBV in Pregnant Women. Answer: At first
prenatal visit
At hospital for birth in women with unknown status or continuing
risk factors for HBV infection
◉ Treatment for HBV infection of pregnant women. Answer: Infants
should receive HBV vaccine and HBIG within 12 hours of birth
,◉ Screening for HBV Infection in General Population. Answer:
Screen all person at high risk for infection
◉ Risk Factors for HBV Infection. Answer: Country of origin
Lack of immunization in persons with parents from a
country/region with high prevalence
HIV infection
Injection Drug Users
Household or sexual contacts of HBV-infected persons
Male homosexuals
Hemodialysis
Immunosuppressive therapy
◉ Treatment for HBV. Answer: Pegylated Interferon-Alpha-2a
entecavir
Tenofovir
◉ Screening for Hepatitis C Infection in General Population. Answer:
Screen all persons at high risk for infection
Screen adults born between 1945 and 1965
,◉ Screening Test for HCV Infection. Answer: Anti-HCV antibody
testing, with confirmatory PCR testing
◉ Risk Factors for HCV Infection. Answer: Past/present injection
drug use
Sex with an injection drug user
Blood transfusion before 1992
Long term hemodialysis
Born to HCV-infected mother
Incarceration
◉ Treatment for HCV Infection. Answer: Pegylated Interferon
plus
Ribavirin for 48 weeks
◉ Screening for HIV. Answer: Screen in adolescents and adults aged
15-65 years
Screen younger adolescents and older adults at increased risk
Screen all pregnant women for HIV
, ◉ Risk Factors for HIV Infection. Answer: Male Homosexuals
Active Injection Drug Users
Exchanging Drugs for Sex or Money
Sexual contact with a known HIV-positive individual
◉ Screening Tests for HIV. Answer: Rapid screening test (positive
results requires work up)
Serum testing: ELISA, followed by confirmatory Western Blot
Immunofluorescent assay
◉ Hyperbilirubinemia Screening in Infants. Answer: USPSTF has
insufficient evidence to recommend screening for
hyperbilirubinemia
◉ Screening for Idiopathic Scoliosis in Asymptomatic Adolescents.
Answer: USPSTF DOES NOT recommend screening for idiopathic
scoliosis in asymptomatic adolescents
◉ Screening for Intimate Partner Violence. Answer: Screen women
of childbearing age for intimate partner violence and provide or
refer women who screen positive to intervention services
LEARNING WORKBOOK 2026 DIAGNOSTIC
APPROACHES AND TREATMENT PROTOCOLS
◉ Screening for Hearing Loss in Adults. Answer: USPSTF has
insufficient evidence to determine the benefits of screening for
hearing loss in asymptomatic adults over the age of 50
◉ Screening for Hepatitis B in Pregnant Women. Answer: Screen all
pregnant women
◉ Screening Test for Hepatitis B in Pregnant Women. Answer:
HBsAg detection, regardless of previous negative HBsAg results
◉ Timing of Screening for HBV in Pregnant Women. Answer: At first
prenatal visit
At hospital for birth in women with unknown status or continuing
risk factors for HBV infection
◉ Treatment for HBV infection of pregnant women. Answer: Infants
should receive HBV vaccine and HBIG within 12 hours of birth
,◉ Screening for HBV Infection in General Population. Answer:
Screen all person at high risk for infection
◉ Risk Factors for HBV Infection. Answer: Country of origin
Lack of immunization in persons with parents from a
country/region with high prevalence
HIV infection
Injection Drug Users
Household or sexual contacts of HBV-infected persons
Male homosexuals
Hemodialysis
Immunosuppressive therapy
◉ Treatment for HBV. Answer: Pegylated Interferon-Alpha-2a
entecavir
Tenofovir
◉ Screening for Hepatitis C Infection in General Population. Answer:
Screen all persons at high risk for infection
Screen adults born between 1945 and 1965
,◉ Screening Test for HCV Infection. Answer: Anti-HCV antibody
testing, with confirmatory PCR testing
◉ Risk Factors for HCV Infection. Answer: Past/present injection
drug use
Sex with an injection drug user
Blood transfusion before 1992
Long term hemodialysis
Born to HCV-infected mother
Incarceration
◉ Treatment for HCV Infection. Answer: Pegylated Interferon
plus
Ribavirin for 48 weeks
◉ Screening for HIV. Answer: Screen in adolescents and adults aged
15-65 years
Screen younger adolescents and older adults at increased risk
Screen all pregnant women for HIV
, ◉ Risk Factors for HIV Infection. Answer: Male Homosexuals
Active Injection Drug Users
Exchanging Drugs for Sex or Money
Sexual contact with a known HIV-positive individual
◉ Screening Tests for HIV. Answer: Rapid screening test (positive
results requires work up)
Serum testing: ELISA, followed by confirmatory Western Blot
Immunofluorescent assay
◉ Hyperbilirubinemia Screening in Infants. Answer: USPSTF has
insufficient evidence to recommend screening for
hyperbilirubinemia
◉ Screening for Idiopathic Scoliosis in Asymptomatic Adolescents.
Answer: USPSTF DOES NOT recommend screening for idiopathic
scoliosis in asymptomatic adolescents
◉ Screening for Intimate Partner Violence. Answer: Screen women
of childbearing age for intimate partner violence and provide or
refer women who screen positive to intervention services
